TP53 and neoplasm: Furthermore, mutant p53 exhibits oncogenic gain-of-function (GOF) properties, reprogramming the tumor microenvironment (TME) to promote immunosuppression, immune evasion, and therapeutic resistance, thereby accelerating tumor progression [18, 19].